Synthetic biology company Ginkgo Bioworks, newly public after a merger with special-purpose acquisition company Soaring Eagle Acquisition Corp., has revealed its ticker symbol: "DNA." Ginkgo ...

Genentech now trades under the ticker symbol DNA. 2004: The FDA approves Genentech's Avastin for colon cancer and Tarceva for lung cancer. March 12: After months of haggling over price ...

We will kick off our investment New Year with a company that was last covered here a year ago, Genentech, ticker symbol DNA on the New York Stock Exchange. My 2008 earnings estimate for Genentech ...

Brian Orelli: Yeah. This was the old Genentech ticker. Genentech the ticker was DNA and then it got acquired twice by Roche. But eventually, it got fully acquired and taken over by Roche.

WITH LOTS OF BUZZ SURROUNDING NEW USES for its blockbuster cancer drug, U.S. biotech giantGenentech (ticker: DNA) offers investors more than the hazy prospect of a big buyout.

"People are very motivated to think of the endgame. How do we make the right drug? How's this going to help the patient? And I think it's that sense of mission that really brings people together ...

Genentech’s third-quarter profit rose 6.7 percent on rising sales of key cancer drugs, the biotechnology company said Tuesday, matching Wall Street’s profit forecasts. The results mark another ...